Literature DB >> 30144314

Detection of intraocular Leptospira spp. by real-time polymerase chain reaction in horses with recurrent uveitis in Belgium.

A C Sauvage1, S J Monclin1, M Elansary2, P Hansen3, M F Grauwels1.   

Abstract

BACKGROUND: Equine recurrent uveitis (ERU) has been associated with Leptospira spp. infection. No information exists concerning the prevalence of Leptospira-associated ERU in Belgium and about the sensitivity of detection of Leptospira in different ocular media.
OBJECTIVES: To establish the prevalence of intraocular Leptospira spp. in ERU-affected and healthy eyes of horses examined at the Equine Clinic of the University of Liège by real-time PCR and to compare the results of the aqueous and vitreous humour of the same eye. STUDY
DESIGN: Cross-sectional.
METHODS: Sixty-six eyes from 59 client-owned horses with a diagnosis of equine recurrent uveitis (ERU-group) were studied from May 2015 to December 2017. Fifty healthy eyes from 28 euthanised horses for unrelated reasons examined during the same period were included in the control group. Intraocular fluids (aqueous and/or vitreous humours) from ERU-affected eyes were sampled and analysed by real-time PCR for Leptospira spp. Aqueous and vitreous humours from the control group were processed in the same way.
RESULTS: Both groups were comparable regarding age, sex, eye sampled (OS/OD), humours sampled (aqueous/vitreous humour) but not regarding breeds, with an over-representation of Warmbloods and Appaloosas in the ERU-group. The prevalence of Leptospira spp. was 30.3% (20/66 eyes) in the ERU-group. Leptospira spp. DNA was identified in 11 aqueous and 17 vitreous humours with eight horses testing positive in both humours, nine horses testing positive for vitreous humour alone and third horses for aqueous humour alone. The phi-correlation between aqueous and vitreous humour Leptospira-PCR results is 0.47 suggesting a low association. All the control eyes were negative. MAIN LIMITATIONS: The diagnostic method selected for this study (lipL32 qPCR) did not allow identification of the serovars.
CONCLUSIONS: Leptospirosis is a potential cause of ERU in Belgium. Testing both intraocular media is advised whenever possible. The Summary is available in Spanish - see Supporting Information.
© 2018 EVJ Ltd.

Entities:  

Keywords:  zzm321990ERUzzm321990; zzm321990PCRzzm321990; Leptospira spp.; aqueous humour; horse; vitreous humour

Mesh:

Year:  2018        PMID: 30144314     DOI: 10.1111/evj.13012

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  5 in total

Review 1.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

2.  Leptospira Seroprevalence in Bardigiano Horses in Northern Italy.

Authors:  Elena Vera; Simone Taddei; Sandro Cavirani; Jennifer Schiavi; Mario Angelone; Clotilde S Cabassi; Emiliana Schiano; Fausto Quintavalla
Journal:  Animals (Basel)       Date:  2019-12-20       Impact factor: 2.752

3.  Analysis of 1840 Equine Intraocular Fluid Samples for the Presence of Anti-Leptospira Antibodies and Leptospiral DNA and the Correlation to Ophthalmologic Findings in Terms of Equine Recurrent Uveitis (ERU)-A Retrospective Study.

Authors:  Tobias Geiger; Hartmut Gerhards; Bogdan Bjelica; Elke Mackenthun; Bettina Wollanke
Journal:  Vet Sci       Date:  2022-08-21

4.  Comparison of Two Leptospira Type Strains of Serovar Grippotyphosa in Microscopic Agglutination Test (MAT) Diagnostics for the Detection of Infections with Leptospires in Horses, Dogs and Pigs.

Authors:  Katrin Strutzberg-Minder; Astrid Ullerich; Karen Dohmann; Jan Boehmer; Marga Goris
Journal:  Vet Sci       Date:  2022-08-29

Review 5.  The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses.

Authors:  Alina Cequier; Carmen Sanz; Clementina Rodellar; Laura Barrachina
Journal:  Animals (Basel)       Date:  2021-03-25       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.